Bioequivalence of BestidineTM Tablet to Dong-A GasterTM Tablet (Famotidine 20 mg) |
Park, Chang-Hun
(Department of Drug Development Service, BioCore Co., Ltd.)
Joung, Sun-Koung (Department of Drug Development Service, BioCore Co., Ltd.) Choi, Mee-Hee (Department of Drug Development Service, BioCore Co., Ltd.) Kim, Ho-Hyun (Department of Pharmacokinetics, Seoul Medical Science Institute, Seoul Clinical Laboratories, Department of Drug Development Service, BioCore Co., Ltd.) Lee, Ye-Rie (Department of Pharmacokinetics, Seoul Medical Science Institute, Seoul Clinical Laboratories, Department of Drug Development Service, BioCore Co., Ltd.) Lee, Hee-Joo (Department of Pharmacokinetics, Seoul Medical Science Institute, Seoul Clinical Laboratories, Department of Drug Development Service, BioCore Co., Ltd.) Lee, Kyung-Ryul (Department of Pharmacokinetics, Seoul Medical Science Institute, Seoul Clinical Laboratories, Department of Drug Development Service, BioCore Co., Ltd.) |
1 | Wanwimoluk, S., Zoest, A. R., Wanwlmoluk, S. Z. and Hung, C. T., Sensitive high-performance liquid chromatographic determination of famotidine in plasma. Int. Jm Chromatogr., 572, 227-238 (1991) DOI ScienceOn |
2 | Y. J. Lee, Y. G. Kim, M. G. Lee, S. J. Chung, M. H. Lee and C. K. Shim, Analysis of bioequivalence study using log-transformed model. Yakhakhoeji, 44,308-314 (2000) |
3 | American Society of Health-System Phannacists, AHFS Drug Information, Famotidine, 2817-2823 (2001) |
4 | Kraemer, H. and Klotz, U., Pharmacokinetics of famotidine in man. Int. J. Clin. Pharmaeol. Ther. Toxieol., 25(8); 458-463 (1987) |
5 | 식품의약품안전청 고시 제2002-60호, 생물학적동등성시험기준(2002. 11. 22). |